- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
-
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
-
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
-
April 3, 2023Conference of Tribal Lending Commissioners
-
April 11-13, 2023Mass Torts Made Perfect Seminar
-
April 19, 2023FBA Women in MDL, Mass and Class Leadership
-
March 2023Unintended Consequences of Banning Noncompete Agreements
-
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
-
March 2023How an Investor Can Lose More Than Just Their Investment
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Robins Kaplan Named Top Firm for Hatch-Waxman Litigation
Four Partners Named Life Science Stars
October 14, 2022
Robins Kaplan LLP is pleased to announce that LMG Life Sciences has recommended the firm as a top Hatch-Waxman patent litigation firm nationwide for generic pharmaceutical companies. In addition, Jake Holdreith, Jeffrey Hovden, Oren Langer, and Ronald Schutz have been named “Life Science Stars.”
- Jake Holdreith is a member of the firm’s Executive Board and the leader of the firm’s life sciences group. He has tried jury cases to multi-million-dollar verdicts and resolved complex cases at all stages of litigation. He is a skilled and creative strategist and business counselor who can cut to the heart of a matter in the boardroom and the courtroom. Based on his accomplishments, Holdreith was recently named Hatch-Waxman Litigator of the Year – Generic by LMG Life Sciences. He is ranked in the areas of General Patent Litigation, Patent Strategy & Management, and Hatch-Waxman Patent Litigation.
- Jeff Hovden practices in the area of patent litigation, with a focus on generic pharmaceutical patent cases under the Hatch-Waxman Act and within the biotechnology industry. He has litigated numerous patent infringement and invalidity actions, including many cases involving top-selling worldwide prescription drugs for both generic and name-brand clients. Hovden routinely advises clients on their intellectual property portfolios and has extensive experience with the Food, Drug, and Cosmetic Act's drug-approval provisions and their attendant regulations. He is ranked in the area of Hatch-Waxman Litigation.
- Oren Langer is Managing Partner of the firm’s New York office. He focuses his practice on intellectual property and technology litigation. His experience spans various industries, including pharmaceuticals (under the Hatch-Waxman Act regulatory framework), chemicals, telecommunications, video gaming, and retail services. Langer also advises clients on licensing negotiations and campaigns, and monetizing intellectual property in anticipation of prospective mergers or acquisitions. He is ranked in the area of Hatch-Waxman Litigation.
- Ronald Schutz is chair of the firm’s Executive Board. He is a fellow of the American College of Trial Lawyers and has been recognized by many legal organizations and publications as one of the top lawyers in the country, including The National Law Journal, which named him one of the “Top 10 Winning Litigators in the United States.” Schutz has won a nine-figure and multiple eight-figure jury verdicts, and has secured victories against behemoths such as Apple, Clear Channel, Sony, and Canon. He is ranked in the areas of General Patent Litigation and Hatch-Waxman Litigation.
Related Professionals
Related Publications
Fourth Quarter
Generically Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Bernard Pound
Fourth Quarter
ANDA Approvals
GENERICally Speaking Hatch Waxman Bulletin
December 27, 2022
Takeda Pharm. Co. Ltd. v. Norwich Pharms., Inc.
GENERICally Speaking Hatch Waxman Bulletin
December 22, 2022
Genentech, Inc. v. Sandoz Inc.
GENERICally Speaking Hatch Waxman Bulletin
December 13, 2022
Vanda Pharms., Inc. v. Teva Pharms. USA, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
September 9, 2022
July 6, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.